Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461–70.
Article
PubMed
Google Scholar
Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol. 2016;140(1):176–83.
Article
PubMed
CAS
Google Scholar
Johnson C, Pankratz VS, Velazquez AI, Aakre JA, Loprinzi CL, Staff NP, Windebank AJ, Yang P. Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients. J Neurol Sci. 2015;349(1–2):124–8.
Article
PubMed
PubMed Central
CAS
Google Scholar
Boora GK, Kanwar R, Kulkarni AA, Abyzov A, Sloan J, Ruddy KJ, Banck MS, Loprinzi CL, Beutler AS. Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (alliance). Cancer Med. 2016;5(4):631–9.
Article
PubMed
PubMed Central
CAS
Google Scholar
Campo C, Da Silva Filho MI, Weinhold N, Goldschmidt H, Hemminki K, Merz M, Forsti A. Genetic susceptibility to Bortezomib-induced peripheral Neuroropathy: replication of the reported candidate susceptibility loci. Neurochem Res. 2017;42(3):925–31.
Article
PubMed
CAS
Google Scholar
Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4(2):45–61.
Article
PubMed
CAS
Google Scholar
Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–11.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sonneveld P, Schmidt-Wolf IG, van der Holt B, El Jarari L, Bertsch U, Salwender H, Zweegman S, Vellenga E, Broyl A, Blau IW, et al. Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/GMMG-HD4 trial. J Clin Oncol. 2012;30(24):2946–55.
Article
PubMed
CAS
Google Scholar
Goldschmidt H, Sonneveld P, Cremer FW, van der Holt B, Westveer P, Breitkreutz I, Benner A, Glasmacher A, Schmidt-Wolf IG, Martin H, et al. Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients. Ann Hematol. 2003;82(10):654–9.
Article
PubMed
CAS
Google Scholar
Mai EK, Bertsch U, Durig J, Kunz C, Haenel M, Blau IW, Munder M, Jauch A, Schurich B, Hielscher T, et al. Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma. Leukemia. 2015;29(8):1721–9.
Article
PubMed
CAS
Google Scholar
Chubb D, Weinhold N, Broderick P, Chen B, Johnson DC, Forsti A, Vijayakrishnan J, Migliorini G, Dobbins SE, Holroyd A, et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet. 2013;45(10):1221–5.
Article
PubMed
PubMed Central
CAS
Google Scholar
Moreau P, San Miguel J, Sonneveld P, Mateos MV, Zamagni E, Avet-Loiseau H, Hajek R, Dimopoulos MA, Ludwig H, Einsele H, et al. Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2017;28(suppl_4):iv52–61.
Article
PubMed
CAS
Google Scholar
Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5(6):e1000529.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930–4.
Article
PubMed
CAS
Google Scholar
Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790–7.
Article
PubMed
PubMed Central
CAS
Google Scholar
Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, et al. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res. 2012;18(18):5099–109.
Article
PubMed
PubMed Central
CAS
Google Scholar
Komatsu M, Wheeler HE, Chung S, Low SK, Wing C, Delaney SM, Gorsic LK, Takahashi A, Kubo M, Kroetz DL, et al. Pharmacoethnicity in paclitaxel-induced sensory peripheral neuropathy. Clin Cancer Res. 2015;21(19):4337–46.
Article
PubMed
PubMed Central
CAS
Google Scholar
Leandro-Garcia LJ, Inglada-Perez L, Pita G, Hjerpe E, Leskela S, Jara C, Mielgo X, Gonzalez-Neira A, Robledo M, Avall-Lundqvist E, et al. Genome-wide association study identifies ephrin type a receptors implicated in paclitaxel induced peripheral sensory neuropathy. J Med Genet. 2013;50(9):599–605.
Article
PubMed
CAS
Google Scholar
Schneider BP, Li L, Radovich M, Shen F, Miller KD, Flockhart DA, Jiang G, Vance G, Gardner L, Vatta M, et al. Genome-wide association studies for Taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199. Clin Cancer Res. 2015;21(22):5082–91.
Article
PubMed
PubMed Central
CAS
Google Scholar
Garcia-Sanz R, Corchete LA, Alcoceba M, Chillon MC, Jimenez C, Prieto I, Garcia-Alvarez M, Puig N, Rapado I, Barrio S, et al. Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array. Hematol Oncol. 2017;35(4):746–51.
Article
PubMed
CAS
Google Scholar
Magrangeas F, Kuiper R, Avet-Loiseau H, Gouraud W, Guerin-Charbonnel C, Ferrer L, Aussem A, Elghazel H, Suhard J, Der Sakissian H, et al. A genome-wide association study identifies a novel locus for Bortezomib-induced peripheral neuropathy in European patients with multiple myeloma. Clin Cancer Res. 2016;22(17):4350–5.
Article
PubMed
PubMed Central
CAS
Google Scholar
Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, et al. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA. 2015;313(8):815–23.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hertz DL, Owzar K, Lessans S, Wing C, Jiang C, Kelly WK, Patel J, Halabi S, Furukawa Y, Wheeler HE, et al. Pharmacogenetic discovery in CALGB (alliance) 90401 and mechanistic validation of a VAC14 polymorphism that increases risk of docetaxel-induced neuropathy. Clin Cancer Res. 2016;22(19):4890–900.
Article
PubMed
PubMed Central
CAS
Google Scholar
Won HH, Lee J, Park JO, Park YS, Lim HY, Kang WK, Kim JW, Lee SY, Park SH. Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients. Cancer. 2012;118(11):2828–36.
Article
PubMed
CAS
Google Scholar
Mahmoudpour SH, Campo C, Da Silva Filho MI, Hemminki K, Goldschmidt H, Merz M, Försti A. Chemotherapy-induced peripheral neuropathy: replication of the results from genome wide association studies within multiple myeloma patients. Pharmacoepidemiol Drug Saf. 2017;26(Suppl. 2):275–6.
Google Scholar
Westra HJ, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, Christiansen MW, Fairfax BP, Schramm K, Powell JE, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45(10):1238–43.
Article
PubMed
PubMed Central
CAS
Google Scholar
Weathington NM, Sznajder JI, Mallampalli RK. The emerging role of the ubiquitin proteasome in pulmonary biology and disease. Am J Respir Crit Care Med. 2013;188(5):530–7.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sanchez-Mora C, Ramos-Quiroga JA, Bosch R, Corrales M, Garcia-Martinez I, Nogueira M, Pagerols M, Palomar G, Richarte V, Vidal R, et al. Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder. Neuropsychopharmacology. 2015;40(4):915–26.
Article
PubMed
CAS
Google Scholar
Ahonen SJ, Pietila E, Mellersh CS, Tiira K, Hansen L, Johnson GS, Lohi H. Genome-wide association study identifies a novel canine glaucoma locus. PLoS One. 2013;8(8):e70903.
Article
PubMed
PubMed Central
CAS
Google Scholar
Saito K, Yamashiro K, Ichikawa Y, Erlmann P, Kontani K, Malhotra V, Katada T. cTAGE5 mediates collagen secretion through interaction with TANGO1 at endoplasmic reticulum exit sites. Mol Biol Cell. 2011;22(13):2301–8.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kummel D, Muller JJ, Roske Y, Misselwitz R, Bussow K, Heinemann U. The structure of the TRAPP subunit TPC6 suggests a model for a TRAPP subcomplex. EMBO Rep. 2005;6(8):787–93.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kheradpour P, Kellis M. Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments. Nucleic Acids Res. 2014;42(5):2976–87.
Article
PubMed
CAS
Google Scholar
Stott SR, Metzakopian E, Lin W, Kaestner KH, Hen R, Ang SL. Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages. J Neurosci. 2013;33(18):8022–34.
Article
PubMed
CAS
Google Scholar
Liu K, Fan J, Wu J. Forkhead box protein J1 (FOXJ1) is overexpressed in colorectal Cancer and promotes nuclear translocation of beta-catenin in SW620 cells. Med Sci Monit. 2017;23:856–66.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhu P, Piao Y, Dong X, Jin Z. Forkhead box J1 expression is upregulated and correlated with prognosis in patients with clear cell renal cell carcinoma. Oncol Lett. 2015;10(3):1487–94.
Article
PubMed
PubMed Central
CAS
Google Scholar
Abraham JE, Guo Q, Dorling L, Tyrer J, Ingle S, Hardy R, Vallier AL, Hiller L, Burns R, Jones L, et al. Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel. Clin Cancer Res. 2014;20(9):2466–75.
Article
PubMed
CAS
Google Scholar
Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton R, Vaughn DJ, Beard C, et al. Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset Cancer. Clin Cancer Res. 2017;23(19):5757–68.
Article
PubMed
CAS
PubMed Central
Google Scholar
Hershman DL, Till C, Wright JD, Awad D, Ramsey SD, Barlow WE, Minasian LM, Unger J. Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in southwest oncology group clinical trials. J Clin Oncol. 2016;34(25):3014–22.
Article
PubMed
PubMed Central
CAS
Google Scholar
Chan JK, Brady MF, Penson RT, Huang H, Birrer MJ, Walker JL, DiSilvestro PA, Rubin SC, Martin LP, Davidson SA, et al. Weekly vs. Every-3-week paclitaxel and carboplatin for ovarian Cancer. N Engl J Med. 2016;374(8):738–48.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hatzi K, Melnick A. Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis. Trends Mol Med. 2014;20(6):343–52.
Article
PubMed
PubMed Central
CAS
Google Scholar
Consortium GT. Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348(6235):648–60.
Article
CAS
Google Scholar
Osakabe A, Takahashi Y, Murakami H, Otawa K, Tachiwana H, Oma Y, Nishijima H, Shibahara KI, Kurumizaka H, Harata M. DNA binding properties of the actin-related protein Arp8 and its role in DNA repair. PLoS One. 2014;9(10):e108354.
Article
PubMed
PubMed Central
CAS
Google Scholar
Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 2006;34(Database issue):D108–10.
Article
PubMed
CAS
Google Scholar
Nakagawa S. A farewell to Bonferroni: the problems of low statistical power and publication bias. Behavioral Ecol. 2004;15(6):1044–5.
Article
Google Scholar
Moreau P, Pylypenko H, Grosicki S, Karamanesht I, Leleu X, Grishunina M, Rekhtman G, Masliak Z, Robak T, Shubina A, et al. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. Lancet Oncol. 2011;12(5):431–40.
Article
PubMed
Google Scholar